World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
16877
World Ranking
3204
National Ranking
217

Ralf R. Schumann publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ralf R. Schumann sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 144 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ralf R. Schumann D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ralf R. Schumann sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ralf R. Schumann is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily spans the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology, with a particular focus on Immunology, Surgery, Epidemiology, Pathology and Forensic Medicine, and Genetics as subfields.

The scientist's work covers a range of topics including Immune Response and Inflammation, Helicobacter pylori-related gastroenterology studies, Pneumonia and Respiratory Infections, Genetic factors in colorectal cancer, Genetic Associations and Epidemiology, NF-κB Signaling Pathways, and Tuberculosis Research and Epidemiology.

Notable recent papers authored or co-authored by Ralf R. Schumann include:

  • Interaction of TLR4 and TLR8 in the Innate Immune Response against Mycobacterium Tuberculosis, 2021, International Journal of Molecular Sciences
  • Dissecting the genetic heterogeneity of gastric cancer, 2023, EBioMedicine
  • RNA Sensing of Mycobacterium tuberculosis and Its Impact on TB Vaccination Strategies, 2020, Vaccines
  • A Genetic Variation of Lipopolysaccharide Binding Protein Affects the Inflammatory Response and Is Associated with Improved Outcome during Sepsis, 2021, ImmunoHorizons
  • Corrigendum to "Dissecting the genetic heterogeneity of gastric cancer", 2023, EBioMedicine

Frequent publication venues for their work include:

  • EBioMedicine
  • International Journal of Molecular Sciences
  • Vaccines
  • ImmunoHorizons

Their collaborations include frequent co-authorship with:

  • Oliver Kumpf
  • Timo Hess
  • Carlo Maj
  • Jan Gehlen
  • Oleg Borisov

Best Publications

  • Structure and function of lipopolysaccharide binding protein

    Ralf R. Schumann;Steven R. Leong;Gail W. Flaggs;Patrick W. Gray

  • Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

    Josef Niebauer;Hans-Dieter Volk;Michael Kemp;Martin Dominguez

  • Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved.

    Nicolas W.J. Schröder;Siegfried Morath;Christian Alexander;Lutz Hamann

  • Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease

    Unknown

  • LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.

    N. Lamping;R. Dettmer;N. W. J. Schroder;D. Pfeil

  • Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria.

    F. P. Mockenhaupt;J. P. Cramer;J. P. Cramer;L. Hamann;M. S. Stegemann

  • Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae.

    Bastian Opitz;Anja Püschel;Bernd Schmeck;Andreas C. Hocke

  • The Role of Toll-like Receptors (TLRs) in Bacteria-induced Maturation of Murine Dendritic Cells (DCs) PEPTIDOGLYCAN AND LIPOTEICHOIC ACID ARE INDUCERS OF DC MATURATION AND REQUIRE TLR2

    Kathrin S. Michelsen;Alexandra Aicher;Mariette Mohaupt;Thomas Hartung

  • TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans

    Bart Ferwerda;Matthew B. B. McCall;Santos Alonso;Evangelos J. Giamarellos-Bourboulis

  • Gram-Negative Bacteria Aggravate Murine Small Intestinal Th1-Type Immunopathology following Oral Infection with Toxoplasma gondii

    Markus M. Heimesaat;Stefan Bereswill;André Fischer;David Fuchs

  • Induction of Cross-Tolerance by Lipopolysaccharide and Highly Purified Lipoteichoic Acid Via Different Toll-Like Receptors Independent of Paracrine Mediators

    Martin D. Lehner;Siegfried Morath;Kathrin S. Michelsen;Ralf R. Schumann

  • Toll-like Receptor-2 Mediates Treponema Glycolipid and Lipoteichoic Acid-induced NF-κB Translocation

    Bastian Opitz;Nicolas W.J. Schröder;Ingo Spreitzer;Kathrin S. Michelsen

  • Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy

    Christopher M. Johnson;Elizabeth A. Lyle;Katherine O. Omueti;Vitaly A. Stepensky

  • Heterozygous Arg753Gln Polymorphism of Human TLR-2 Impairs Immune Activation by Borrelia burgdorferi and Protects from Late Stage Lyme Disease

    Nicolas W J Schröder;Isabel Diterich;Antje Zinke;Jana Eckert

  • Escherichia coli Strain Nissle 1917 Ameliorates Experimental Colitis via Toll-Like Receptor 2- and Toll-Like Receptor 4-Dependent Pathways

    A Grabig;D. Paclik;C. Guzy;A. Dankof

  • Targeted Deletion of the Lipopolysaccharide (LPS)-binding Protein Gene Leads to Profound Suppression of LPS Responses Ex Vivo, whereas In Vivo Responses Remain Intact

    Mark M. Wurfel;Brian G. Monks;Robin R. Ingalls;Russell L. Dedrick

  • Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4.

    Markus M. Heimesaat;André Fischer;Britta Siegmund;Andreas Kupz

  • The role of lipopolysaccharide-binding protein in modulating the innate immune response.

    Janine Zweigner;Ralf R. Schumann;Joerg R. Weber

  • TLR2: Cellular Sensor for Microbial and Endogenous Molecular Patterns

    Unknown

  • Lipopolysaccharide Binding Protein Binds to Triacylated and Diacylated Lipopeptides and Mediates Innate Immune Responses

    Nicolas W. J. Schröder;Holger Heine;Christian Alexander;Maria Manukyan

  • Escherichia coli nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling

    Andreas Sturm;Klaus Rilling;Daniel C. Baumgart;Konstantinos Gargas

  • Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli

    Markus M Heimesaat;André Fischer;Hannah-Katharina Jahn;Julia Niebergall

  • Streptococcal M protein: a multipotent and powerful inducer of inflammation.

    Lisa I. Påhlman;Matthias Mörgelin;Jana Eckert;Linda Johansson

  • Common Polymorphisms of Toll-Like Receptors 4 and 9 Are Associated with the Clinical Manifestation of Malaria during Pregnancy

    Frank P. Mockenhaupt;Lutz Hamann;Christiane von Gaertner;George Bedu-Addo

  • Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule

    Ralf R. Schumann

  • Toll-like receptor 4 plays a crucial role in the immune–adrenal response to systemic inflammatory response syndrome

    Kai Zacharowski;Paula A. Zacharowski;Alexander Koch;Aida Baban

  • Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation.

    N Lamping;A Hoess;B Yu;T C Park

Frequent Co-Authors

Frank P. Mockenhaupt
Frank P. Mockenhaupt Charité - University Medicine Berlin
Ulf B. Göbel
Ulf B. Göbel Charité - University Medicine Berlin
Carsten J. Kirschning
Carsten J. Kirschning University of Duisburg-Essen
Thomas Hartung
Thomas Hartung Johns Hopkins University
Ulrich Bienzle
Ulrich Bienzle Charité - University Medicine Berlin
Evangelos J. Giamarellos-Bourboulis
Evangelos J. Giamarellos-Bourboulis National and Kapodistrian University of Athens
Andre Franke
Andre Franke Kiel University
Ulrich Zähringer
Ulrich Zähringer Research Center Borstel - Leibniz-Center for Medicine and Biosciences
Jos W. M. van der Meer
Jos W. M. van der Meer Radboud University Medical Center
Margitta Worm
Margitta Worm Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing advanced nursing degrees can provide valuable career opportunities within healthcare and research settings. Many students consider accelerated RN to NP programs, which offer a streamlined path to becoming a Nurse Practitioner with specialized knowledge, including acute care options. Exploring these programs online can make balancing study with work much easier.

Nurses aiming to expand their expertise might also explore acute care nurse practitioner programs. These prepare professionals to diagnose and manage complex conditions in hospital environments, which often intersect with immunological care. Transitioning from general practice to acute care roles can significantly broaden career possibilities.

For individuals beginning their healthcare education, online BSN programs for non nurses offer a flexible entry point into nursing without prior clinical experience. This foundational degree supports further advancement into specialized areas like immunology and advanced practice nursing through graduate programs.

Understanding salary expectations is crucial for career planning. Insights into dnp salary by state can help prospective students gauge the financial benefits of advanced degrees such as the Doctor of Nursing Practice, emphasizing the value of investing in higher education.

By leveraging these educational pathways and resources, students and professionals can effectively align their immunology interests with rewarding nursing careers.

Best Scientists Citing Ralf R. Schumann

Trending Scientists